Research Article
Immunogenicity of Simulated PCECV Postexposure Booster Doses 1, 3, and 5 Years after 2-Dose and 3-Dose Primary Rabies Vaccination in Schoolchildren
Table 1
Number and percentage of children reaching adequate RVNA concentrations (≥0.5 IU/mL) after administration of simulated post-exposure booster doses, 1, 3, or 5 years after two or three primary vaccination doses, as determined by RFFIT.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2d: two-dose primary vaccination; 3d: three-dose primary vaccination; pre: before booster. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||